Alendronic acid not cost effective for postmenopausal osteopenia

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1498, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alendronic acid not cost effective for postmenopausal osteopenia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 483, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Alendronic acid effective for osteoporosis in men

Inpharma, Vol. 1, Iss. 1254, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Alendronic acid appears to be more effective than risedronic acid for preventing fractures in patients with rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Risk of fracture with alendronic acid

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Alendronic acid: Oesophagitis: case report

Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite